- Home
- LXRX vs DBI Comparison
LXRX vs DBI Comparison
Compare LXRX & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXRX
- DBI
- Stock Information
- Founded
- LXRX 1995
- DBI 1991
- Country
- LXRX United States
- DBI United States
- Employees
- LXRX N/A
- DBI N/A
- Industry
- LXRX Biotechnology: Pharmaceutical Preparations
- DBI Clothing/Shoe/Accessory Stores
- Sector
- LXRX Health Care
- DBI Consumer Discretionary
- Exchange
- LXRX Nasdaq
- DBI Nasdaq
- Market Cap
- LXRX 283.7M
- DBI 250.2M
- IPO Year
- LXRX 2000
- DBI 1991
- Fundamental
- Price
- LXRX $0.71
- DBI $4.78
- Analyst Decision
- LXRX Buy
- DBI Hold
- Analyst Count
- LXRX 2
- DBI 2
- Target Price
- LXRX $4.00
- DBI $5.75
- AVG Volume (30 Days)
- LXRX 4.1M
- DBI 1.7M
- Earning Date
- LXRX 03-10-2025
- DBI 03-20-2025
- Dividend Yield
- LXRX N/A
- DBI 4.12%
- EPS Growth
- LXRX N/A
- DBI N/A
- EPS
- LXRX N/A
- DBI N/A
- Revenue
- LXRX $5,229,000.00
- DBI $3,050,038,000.00
- Revenue This Year
- LXRX $842.94
- DBI N/A
- Revenue Next Year
- LXRX $19.76
- DBI $2.16
- P/E Ratio
- LXRX N/A
- DBI N/A
- Revenue Growth
- LXRX 886.60
- DBI N/A
- 52 Week Low
- LXRX $0.62
- DBI $4.36
- 52 Week High
- LXRX $2.83
- DBI $11.57
- Technical
- Relative Strength Index (RSI)
- LXRX 43.33
- DBI 39.62
- Support Level
- LXRX $0.66
- DBI $5.05
- Resistance Level
- LXRX $0.97
- DBI $5.30
- Average True Range (ATR)
- LXRX 0.07
- DBI 0.27
- MACD
- LXRX -0.00
- DBI -0.02
- Stochastic Oscillator
- LXRX 16.13
- DBI 16.90
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.